nsc 664704 has been researched along with Hepatitis B in 1 studies
kenpaullone: inhibits CDK1/cyclin B; structure in first source
kenpaullone : An indolobenzazepine that is paullone in which the hydrogen at position 9 is replaced by a bromo substituent. It is an ATP-competitive inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3beta (GSK3beta).
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchmann, B | 1 |
| Döhner, K | 1 |
| Schirdewahn, T | 1 |
| Sodeik, B | 1 |
| Manns, MP | 1 |
| Wedemeyer, H | 1 |
| Ciesek, S | 1 |
| von Hahn, T | 1 |
1 other study available for nsc 664704 and Hepatitis B
| Article | Year |
|---|---|
A screening assay for the identification of host cell requirements and antiviral targets for hepatitis D virus infection.
Topics: Antibodies, Monoclonal; Antiviral Agents; Automation; Benzazepines; Coinfection; Hepatitis Antibodie | 2017 |